Immuno-Biological Laboratories Co., Ltd. Japan

Research

Date range: 1 February 2022 - 31 January 2023

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Immuno-Biological Laboratories Co., Ltd. published between 1 February 2022 - 31 January 2023 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Immuno-Biological Laboratories Co., Ltd.
Count Share
1 0.02

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.02

Share output for the past 5 years

Share per year
2018 2019 2020 2021 2022
0.33 0.00 0.25 0.00 0.02

Compare Immuno-Biological Laboratories Co., Ltd. with other institutions

Nature Strategy Reports

Nature Strategy Reports gives you simple insights to support decisions that impact your organisation

The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.

Collaboration

Date range: 1 February 2022 - 31 January 2023

International vs. domestic collaboration by Share

  • 16.00% Domestic (1 institutions)
  • 84.00% International (6 institutions)

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Immuno-Biological Laboratories Co., Ltd. by Share*

  1. Immuno-Biological Laboratories Co., Ltd. and Gunma University (0.18)
    Immuno-Biological Laboratories Co., Ltd.0.02
    Gunma University0.16

Top 10 international collaborators with Immuno-Biological Laboratories Co., Ltd. by Share*

  1. Immuno-Biological Laboratories Co., Ltd. and University of California, Los Angeles (UCLA) (0.48)
    Immuno-Biological Laboratories Co., Ltd.0.02
    University of California, Los Angeles (UCLA)0.45
  2. Immuno-Biological Laboratories Co., Ltd. and University of California, San Francisco (UCSF) (0.11)
    Immuno-Biological Laboratories Co., Ltd.0.02
    University of California, San Francisco (UCSF)0.09
  3. Immuno-Biological Laboratories Co., Ltd. and Rigshospitalet (0.11)
    Immuno-Biological Laboratories Co., Ltd.0.02
    Rigshospitalet0.09
  4. Immuno-Biological Laboratories Co., Ltd. and University of Copenhagen (UCPH) (0.11)
    Immuno-Biological Laboratories Co., Ltd.0.02
    University of Copenhagen (UCPH)0.09
  5. Immuno-Biological Laboratories Co., Ltd. and Harvard University (0.07)
    Immuno-Biological Laboratories Co., Ltd.0.02
    Harvard University0.05
  6. Immuno-Biological Laboratories Co., Ltd. and The University of Hong Kong (HKU) (0.07)
    Immuno-Biological Laboratories Co., Ltd.0.02
    The University of Hong Kong (HKU)0.05

*Share is the fractional count allocated to an institution for an article that takes into account the percentage of authors from that institution and the number of affiliated institutions that contributed to the article. The horizontal stacked bar charts above indicate the Share contributed by each institution in the bilateral collaboration. If the Share is not shown, hover over the bar to display it.